Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis

BACKGROUND: To identify high-risk patients and provide pharmacological treatment is one of the effective approaches in prevention of osteoporotic fractures. This study investigated the effect of 12-month Alendronate treatment on bone mineral density (BMD) and bone turnover biochemical markers in pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Ling, Choy, Wingyee, Au, Szeki, Fan, Musei, Leung, Pingchung
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885425/
https://www.ncbi.nlm.nih.gov/pubmed/17511887
http://dx.doi.org/10.1186/1749-799X-2-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885425/
https://www.ncbi.nlm.nih.gov/pubmed/17511887
http://dx.doi.org/10.1186/1749-799X-2-9

Ejemplares similares